FDA Approved: LOXAPINE — Supplemental Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved a supplemental application for LOXAPINE from Lannett Company, Inc., granting regulatory approval for an updated/expanded generic LOXAPINE product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• LOXAPINE (loxapine)

Snippet

SUPPL AP for LOXAPINE (LOXAPINE)